MedTrace Logo

Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties, Phase II

NCT01706406 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2017-06-01

No results posted yet for this study

Summary

The purpose of this study is to pilot test and determine the efficacy of a psychoeducational intervention (PED) we recently piloted in a group format for women with acquired sexual arousal disorder (FSAD).

HYPOTHESES:

1. \- Compared to baseline measures, the PED will result in significant improvement in self-report measures of: (a) subjective sexual arousal; (b) perception of genital arousal/genital sensitivity; (c) orgasmic experience; (d) sexual desire; (e) sexual distress; (f) relationship satisfaction; (g) depressive symptoms; and (h) quality of life.
2. \- It is unknown what effect the PED will have on actual physiological sexual arousal.
3. \- The group format will be a feasible and cost-effective method of delivering empirically supported treatment to women with sexual arousal difficulties and will contribute towards meeting the needs for sexual health care for women on the clinic wait-list at the BC Centre for Sexual Medicine.

Conditions

  • Low Female Sexual Arousal
  • Low Female Sexual Desire

Interventions

BEHAVIORAL

Brief psychoeducational intervention for female sexual arousal disorder

four 1.5 hour long group psychoeducational sessions, spaced 2 weeks apart for a total of 8 weeks.

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Lori A Brotto, PhD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01706406 on ClinicalTrials.gov